ONEMAP
LIVE

Serial Number

79436458

Owner

ONE BIOSCIENCES

Attorney

Pamela N. Hirschman

Filing Date

Aug 1, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ONEMAP Trademark

Serial Number: 79436458

ONEMAP is a trademark filed by ONE BIOSCIENCES on August 1, 2025. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

ONE BIOSCIENCES (3 trademarks)

101 Rue de Sèvres

Entity Type: 98

Trademark Details

Filing Date

August 1, 2025

Registration Date

Not Registered

Published for Opposition

August 11, 2026

Goods & Services

Database management; collection of data, namely, medical, chemistry and biological data, for business purposes; data systematization in computer databases; provision of data, namely, providing a database featuring consumer product information in the field of medical diagnostic products; compilation of information in computer databases; services for gathering data in computer databases, namely, compilation of information into computer databases; systematization of information in computer databases; data processing services; updating of data and metadata in computer databases; subscriptions to database services, namely, arranging of subscriptions to databases for others, by telecommunications; all the aforesaid services in the fields of biological and chemical analyses, medical diagnostics and clinical trials

Downloadable software and downloadable software application for biological, chemical and medical analysis; downloadable software and downloadable software applications for medical diagnosis; downloadable electronic databases in the fields of biology, chemistry and medicine

Design, development, installation, updating, maintenance of software; Software as a Service (SaaS) featuring software for biological, chemical and medical analysis; design and development of databases; conducting of scientific and technical studies, namely, conducting scientific feasibility studies and feasibility studies in the fields of biology, chemistry and medicine; scientific and technological research and design services, and scientific analysis, in the field of medical diagnostics; development and testing of methods and algorithms in the field of medical diagnostics; electronic data storage; hosting of databases; all the aforesaid services being in the fields of biological and chemical analyses, medical diagnostics and clinical trials

Single-cell medical testing and analysis services for cancer prognosis, diagnosis and treatment as well as for diagnosis or treatment of other diseases; medical services; diagnostic services, namely, medical diagnostic testing for cancer as well as for other diseases and disorders; medical tests, namely, medical testing services, for diagnostic or treatment purposes; medical testing for the diagnosis and treatment of persons; laboratory analysis services, namely, medical laboratory analysis, blood analysis services provided by medical laboratories, relating to the treatment of persons; medical services in the field of oncology and other medical fields; provision of medical information in the field of health; providing screening services for cancer and other diseases, namely, providing medical diagnostic testing services consisting essentially of chemical analysis and use of bioinformatics tools for cancer screening; provision of medical information collected and analyzed for the purpose of diagnosis or treatment of cancer and other diseases and disorders; provision of medical data, namely, data about cancer treatment options and medical information intended for healthcare professionals.

Filing History

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 15, 2026 GNEN
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 15, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 15, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
Jul 15, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 15, 2026 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 15, 2026 GNFN
FINAL REFUSAL E-MAILED
Jul 15, 2026 GNFR
FINAL REFUSAL WRITTEN
Jul 15, 2026 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 2, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 2, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 2, 2026 TROA
REFUSAL PROCESSED BY IB
Mar 5, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 18, 2026 RFCS
REFUSAL PROCESSED BY MPU
Feb 18, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 23, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jan 22, 2026 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Jan 21, 2026 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 18, 2025 RFCR
NON-FINAL ACTION WRITTEN
Dec 17, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 16, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 8, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 8, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 6, 2025 REPR